DEA Telehealth Regulations on COVID-19 and Prescriptions

March 25, 2020 by Mandy Qualls

Filed under COVID-19 for Employers, For Employers, Regulations, Telehealth

Last modified March 30, 2020

As of March 16, 2020, and continuing for as long as the Secretary’s designation of a public health emergency remains in effect, DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met:

  • The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice;
  • The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system; and
  • The practitioner is acting in accordance with applicable Federal and State laws.

https://www.deadiversion.usdoj.gov/coronavirus.html

Share this

Related Articles

                            Leave a Comment